Sarepta Therapeutics, Inc. Business Operations Contracts & Agreements
21 Contracts & Agreements
- Agency Agreements (2 contracts)
- Collaboration Agreements (15)
- Development Agreements (1)
- Indemnification Agreements (1)
- Settlement Agreements (1)
- Supply Agreements (1)
- Amendment no. 14 dated October 31, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on February 28, 2024)
- Amendment no. 13 dated August 31, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on February 28, 2024)
- Amendment no. 12 dated July 28, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on February 28, 2024)
- Amendment no. 11 dated June 23, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on February 28, 2024)
- Amendment no. 9 dated March 23, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on August 2, 2022)
- Amendment no. 8 dated January 28, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on March 1, 2022)
- Amendment no. 7 dated January 5, 2022 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on March 1, 2022)
- Amendment no. 6 dated November 30, 2021 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on March 1, 2022)
- Amendment no. 5 dated August 31, 2021 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21,... (Filed With SEC on November 3, 2021)
- Amendment no. 4 dated June 23, 2021 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21, 2019 (Filed With SEC on August 4, 2021)
- Amendment no. 3 dated February 4, 2021 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on August 4, 2021)
- Amendment no. 2 dated October 28, 2020 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd, dated December 21,... (Filed With SEC on August 4, 2021)
- Amendment no. 1 dated October 23, 2020 to the License, Collaboration, and Option Agreement between Sarepta Therapeutics Three, LLC and F. Hoffman-La Roche Ltd dated December 21,... (Filed With SEC on August 4, 2021)
- Settlement Agreement between Sarepta Therapeutics, Inc., Sarepta International C.V. and The University of Western Australia on the one hand, and BioMarin Leiden Holding BV,... (Filed With SEC on August 3, 2017)
- Amendment No. 1 to the License and Collaboration Agreement between Summit (Oxford) Ltd. and Sarepta Therapeutics Inc. dated June 13, 2017 (Filed With SEC on August 3, 2017)
- AVI BIOPHARMA, INC. FORM OF INDEMNIFICATION AGREEMENT (Filed With SEC on October 8, 2010)
- Defense Threat Reduction Agency (Filed With SEC on August 9, 2010)
- COLLABORATION AND LICENSE AGREEMENT (Filed With SEC on March 16, 2010)
- Defense Threat Reduction Agency 8725 John J. Kingman Road, MSC 6201 Fort Belvoir, VA 22060-6201 (Filed With SEC on August 10, 2009)
- SUPPLY AGREEMENT 1 (Filed With SEC on August 14, 2001)
- LICENSEAND DEVELOPMENT AGREEMENT 1 (Filed With SEC on August 14, 2001)
